Human mesothelioma induces defects in dendritic cell numbers and antigen processing function which predict survival outcomes
AbstractMesothelioma is an almost invariably fatal tumor with chemotherapy extending survival by a few months. One immunotherapeutic strategy is to target dendritic cells (DCs), key antigen presenting cells involved in antigen presentation, to induce antigen-specific T cell responses. However, DC-ta...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
Taylor & Francis
2015
|
| Online Access: | http://hdl.handle.net/20.500.11937/18165 |
Similar Items
Studies on the Effect of Aging and Mesothelioma on Dendritic Cell Subsets
by: Cornwall, Scott M.J.
Published: (2015)
by: Cornwall, Scott M.J.
Published: (2015)
Elderly dendritic cells respond to LPS/IFN-γ and CD40L stimulation despite incomplete maturation
by: Gardner, J., et al.
Published: (2018)
by: Gardner, J., et al.
Published: (2018)
Mesothelioma tumor cells modulate dendritic cell lipid content, phenotype and function
by: Gardner, J., et al.
Published: (2015)
by: Gardner, J., et al.
Published: (2015)
Predicting survival in malignant mesothelioma
by: Musk, A., et al.
Published: (2011)
by: Musk, A., et al.
Published: (2011)
CD40-activated B cells contribute to mesothelioma tumor regression
by: Jackaman, Connie, et al.
Published: (2011)
by: Jackaman, Connie, et al.
Published: (2011)
SURVIVAL IN MESOTHELIOMA: AN ANALYSIS OF DIFFERENT DIAGNOSTIC TECHNIQUES
by: Muruganandan, S., et al.
Published: (2016)
by: Muruganandan, S., et al.
Published: (2016)
Ageing and Mesothelioma Drive Lipid Accumulation and Dysfunction in Dendritic Cells and Macrophages
by: Sheeraz, Mohd
Published: (2022)
by: Sheeraz, Mohd
Published: (2022)
PREDICTION MODELING USING ROUTINE CLINICAL PARAMETERS TO STRATIFY SURVIVAL IN MESOTHELIOMA PATIENTS UNDERGOING SURGERY
by: Harris, E., et al.
Published: (2017)
by: Harris, E., et al.
Published: (2017)
ROUTINELY COLLECTED CLINICAL AND LABORATORY DATA CAN RELIABLY PREDICT LONGER SURVIVAL IN MALIGNANT PLEURAL MESOTHELIOMA
by: Brims, Fraser, et al.
Published: (2014)
by: Brims, Fraser, et al.
Published: (2014)
Routinely Collected Clinical And Laboratory Data Can Reliably Predict Longer Survival In Malignant Pleural Mesothelioma
by: Brims, Fraser, et al.
Published: (2014)
by: Brims, Fraser, et al.
Published: (2014)
Mesothelioma in australia: A review
by: Musk, A., et al.
Published: (2017)
by: Musk, A., et al.
Published: (2017)
Comparison of outcomes following a cytological or histological diagnosis of malignant mesothelioma
by: Muruganandan, S., et al.
Published: (2017)
by: Muruganandan, S., et al.
Published: (2017)
Chemotherapy broadens the range of tumor antigens seen by cytotoxic CD8+ T cells in vivo
by: Jackaman, Connie, et al.
Published: (2012)
by: Jackaman, Connie, et al.
Published: (2012)
Statins do not alter the incidence of mesothelioma in asbestos exposed mice or humans
by: Robinson, C., et al.
Published: (2014)
by: Robinson, C., et al.
Published: (2014)
Further exploration of the Dendritic Cell Algorithm: antigen multiplier and time windows
by: Gu, Feng, et al.
Published: (2008)
by: Gu, Feng, et al.
Published: (2008)
Prediction modelling using routine clinical parameters to stratify survival in Malignant Pleural Mesothelioma patients undergoing cytoreductive surgery.
by: Harris, E., et al.
Published: (2018)
by: Harris, E., et al.
Published: (2018)
Epidemiology of Malignant Pleural Mesothelioma in Australia
by: De Klerk, N., et al.
Published: (2016)
by: De Klerk, N., et al.
Published: (2016)
Asbestos exposure and histological subtype of malignant mesothelioma
by: Franklin, P., et al.
Published: (2016)
by: Franklin, P., et al.
Published: (2016)
Asbestos Related non-Malignant Pleural Disease and Mesothelioma
by: Musk, B., et al.
Published: (2016)
by: Musk, B., et al.
Published: (2016)
Serum mesothelin for early detection of asbestos-induced cancer malignant mesothelioma
by: Creaney, J., et al.
Published: (2010)
by: Creaney, J., et al.
Published: (2010)
Effect of NSAIDS and COX-2 inhibitors on the incidence and severity of asbestos-induced malignant mesothelioma: Evidence from an animal model and a human cohort
by: Robinson, C., et al.
Published: (2014)
by: Robinson, C., et al.
Published: (2014)
MESOTHELIOMA IN AUSTRALIA-RESULTS FROM THE AUSTRALIAN MESOTHELIOMA REGISTRY
by: Sim, M., et al.
Published: (2016)
by: Sim, M., et al.
Published: (2016)
Pattern of malignant mesothelioma incidence and occupational exposure to asbestos in Western Australia.
by: Musk, A., et al.
Published: (2015)
by: Musk, A., et al.
Published: (2015)
Incidence of malignant mesothelioma in Aboriginal people in Western Australia.
by: Franklin, P., et al.
Published: (2016)
by: Franklin, P., et al.
Published: (2016)
IL-2/CD40-driven NK cells install and maintain potency in the anti-mesothelioma effector/memory phase
by: Jackaman, Connie, et al.
Published: (2012)
by: Jackaman, Connie, et al.
Published: (2012)
Are children more vulnerable to mesothelioma than adults? A comparison of mesothelioma risk among children and adults exposed non-occupationally to blue asbestos at Wittenoom
by: Reid, Alison, et al.
Published: (2018)
by: Reid, Alison, et al.
Published: (2018)
Modulation of dendritic cell and T cell cross-talk during aging: The potential role of checkpoint inhibitory molecules
by: Gardner, J., et al.
Published: (2017)
by: Gardner, J., et al.
Published: (2017)
Palliative care in mesothelioma
by: Brims, Fraser
Published: (2018)
by: Brims, Fraser
Published: (2018)
Murine mesothelioma induces locally-proliferating IL-10+TNF-a+CD206-CX3CR1+ M3 macrophages that can be selectively depleted by chemotherapy or immunotherapy
by: Jackaman, Connie, et al.
Published: (2016)
by: Jackaman, Connie, et al.
Published: (2016)
Rapid copper acquisition by developing murine mesothelioma: Decreasing bioavailable copper slows tumor growth, normalizes vessels and promotes T cell infiltration
by: Crowe, Andrew, et al.
Published: (2013)
by: Crowe, Andrew, et al.
Published: (2013)
Postmortem findings of malignant pleural mesothelioma: A two-center study of 318 patients
by: Finn, R., et al.
Published: (2012)
by: Finn, R., et al.
Published: (2012)
Effect of O-linked glycosylation on the antigenicity, cellular uptake and trafficking in dendritic cells of recombinant Ber e 1
by: Jambari, Nuzul Noorahya, et al.
Published: (2021)
by: Jambari, Nuzul Noorahya, et al.
Published: (2021)
Aging induces increased expression of checkpoint inhibitory molecules on dendritic cells
by: Gardner, J., et al.
Published: (2016)
by: Gardner, J., et al.
Published: (2016)
Familial aggregation of malignant mesothelioma in former workers and residents of Wittenoom, Western Australia
by: De Klerk, N., et al.
Published: (2013)
by: De Klerk, N., et al.
Published: (2013)
Henoch-Schonlein purpura in mesothelioma
by: Joshi, S., et al.
Published: (2014)
by: Joshi, S., et al.
Published: (2014)
Wnt Signalling in Malignant Mesothelioma
by: Richards, Alexander S.K.
Published: (2016)
by: Richards, Alexander S.K.
Published: (2016)
Risk factors for malignant mesothelioma in people with no known exposure to asbestos
by: Musk, B., et al.
Published: (2017)
by: Musk, B., et al.
Published: (2017)
Predicted mortality from malignant mesothelioma among women exposed to blue asbestos at Wittenoom, Western Australia
by: Reid, Alison, et al.
Published: (2009)
by: Reid, Alison, et al.
Published: (2009)
A genome-wide association study for malignant mesothelioma risk
by: Cadby, G., et al.
Published: (2013)
by: Cadby, G., et al.
Published: (2013)
Absence of germline mutations in BAP1 in sporadic cases of malignant mesothelioma
by: Sneddon, S., et al.
Published: (2015)
by: Sneddon, S., et al.
Published: (2015)